focus -WSS

focus

author：leisure time 2025-09-30 08:45:57 - browse：3

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： ActiGraph execs on goal of drug approvals with digital endpoints

entertainment

WSS

Trump cancels press conference intended to dispute Georgia election interference charges

Hilary expected to bring catastrophic, life

Winners, losers from Medicare’s list of drugs subject to price talks

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Appeals court upholds limits to abortion pill

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

explore

Apple is now the first public company to be valued at $3 trillion

CDC advisory panel says seniors 'may' get RSV vaccine

Jerome Adams on the need for new antivirals for Covid

Complete sequence of Y chromosome published for first time

Medical leaders decry Supreme Court decision on affirmative action

How a symptom of dementia informs our understanding of creativity

What does generative AI mean for health care? We asked experts

Cancer drug shortages' outsize impact on ovarian cancer patients

Drug repurposing or repositioning? The language matters

Ukraine taking heavy casualties 10 weeks into its counteroffensive

hotspot

Cancer drug shortages' outsize impact on ovarian cancer patients

Why more medical students aren't specializing in primary care

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Baltimore teen accused of firing into crowd during block party mass shooting

Listen: Racing for gene therapy & a pioneering approval

Trump cancels press conference intended to dispute Georgia election interference charges

entertainment

hotspot

entertainment

focus